Novel aspects of complement in kidney injury.

[1]  Gerhard Opelz,et al.  C3 polymorphisms and allograft outcome in renal transplantation. , 2009, The New England journal of medicine.

[2]  A. Butte,et al.  Expression of complement components differs between kidney allografts from living and deceased donors. , 2009, Journal of the American Society of Nephrology : JASN.

[3]  P. Heeger,et al.  Primed CD8+ T‐Cell Responses to Allogeneic Endothelial Cells Are Controlled by Local Complement Activation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  C. Alpers,et al.  Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells. , 2009, The Journal of clinical investigation.

[5]  N. Sheerin,et al.  C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy. , 2009, Journal of the American Society of Nephrology : JASN.

[6]  C. Parker.  Eculizumab for paroxysmal nocturnal haemoglobinuria , 2009, The Lancet.

[7]  K. Schnatbaum,et al.  Complement 5a receptor inhibition improves renal allograft survival. , 2008, Journal of the American Society of Nephrology : JASN.

[8]  R. Starling,et al.  Complement Gene Expression in Human Cardiac Allograft Biopsies as a Correlate of Histologic Grade of Injury , 2008, Transplantation.

[9]  Motohiko Suzuki,et al.  Gene silencing of complement C5a receptor using siRNA for preventing ischemia/reperfusion injury. , 2008, The American journal of pathology.

[10]  P. Heeger,et al.  Donor Deficiency of Decay-Accelerating Factor Accelerates Murine T Cell-Mediated Cardiac Allograft Rejection1 , 2008, The Journal of Immunology.

[11]  Wuding Zhou,et al.  New boundaries for complement in renal disease. , 2008, Journal of the American Society of Nephrology : JASN.

[12]  P. Heeger,et al.  Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. , 2008, Blood.

[13]  J. Köhl,et al.  Pharmacological targeting of C5a receptors during organ preservation improves kidney graft survival , 2008, Clinical and experimental immunology.

[14]  V. Tuohy,et al.  IFN-γ and IL-17 Production in Experimental Autoimmune Encephalomyelitis Depends on Local APC–T Cell Complement Production1 , 2008, The Journal of Immunology.

[15]  P. Risley,et al.  Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  G. Dubyak,et al.  Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. , 2008, Immunity.

[17]  J. Atkinson,et al.  Complement regulatory genes and hemolytic uremic syndromes. , 2008, Annual review of medicine.

[18]  P. Heeger,et al.  Decay Accelerating Factor Can Control T Cell Differentiation into IFN-γ-Producing Effector Cells via Regulating Local C5a-Induced IL-12 Production1 , 2007, The Journal of Immunology.

[19]  P. Heeger,et al.  Graft-derived complement as a mediator of transplant injury. , 2007, Current opinion in immunology.

[20]  J. Lambris,et al.  C3a Is Required for the Production of CXC Chemokines by Tubular Epithelial Cells after Renal Ishemia/Reperfusion1 , 2007, The Journal of Immunology.

[21]  R. Vaughan,et al.  Influence of donor C3 allotype on late renal-transplantation outcome. , 2006, The New England journal of medicine.

[22]  N. Sheerin,et al.  Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. , 2006, The American journal of pathology.

[23]  Wuding Zhou,et al.  Local Extravascular Pool of C3 Is a Determinant of Postischemic Acute Renal Failure , 2022 .

[24]  M. Nangaku,et al.  Mechanisms of immune-deposit formation and the mediation of immune renal injury , 2005, Clinical and Experimental Nephrology.

[25]  A. Valujskikh,et al.  Decay-accelerating factor modulates induction of T cell immunity , 2005, The Journal of experimental medicine.

[26]  M. Carroll,et al.  The complement system in regulation of adaptive immunity , 2004, Nature Immunology.

[27]  R. Smith,et al.  Nontransgenic hyperexpression of a complement regulator in donor kidney modulates transplant ischemia/reperfusion damage, acute rejection, and chronic nephropathy. , 2003, The American journal of pathology.

[28]  S. Sacks,et al.  Local synthesis of complement component C3 regulates acute renal transplant rejection , 2002, Nature Medicine.

[29]  K. Abe,et al.  In situ localization of C3 synthesis in experimental acute renal allograft rejection. , 2000, The American journal of pathology.

[30]  R. Colvin,et al.  Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. , 1999, Journal of the American Society of Nephrology : JASN.

[31]  V. Nussenzweig,et al.  Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes , 1984, The Journal of experimental medicine.